Schubert & Co’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-8
| Closed | -$810 | – | 976 |
|
|
2023
Q1 | $810 | Hold |
8
| – | – | ﹤0.01% | 1284 |
|
|
2022
Q4 | $956 | Buy |
8
+1
| +14% | +$120 | ﹤0.01% | 1193 |
|
|
2022
Q3 | $1K | Buy |
7
+2
| +40% | +$286 | ﹤0.01% | 1178 |
|
|
2022
Q2 | $0 | Sell |
5
-1
| -17% | – | ﹤0.01% | 1540 |
|
|
2022
Q1 | $1K | Buy |
6
+2
| +50% | +$333 | ﹤0.01% | 814 |
|
|
2021
Q4 | $0 | Buy |
+4
| New | – | ﹤0.01% | 1186 |
|